Histological and Clinicopathological Evaluation of Liver Allograft Biopsy: An Initial Experience of Fifty Six Biopsies

Liver biopsy is gold standard for diagnosis of allograft dysfunction. The aim of study was to evaluate liver allograft biopsies performed for graft dysfunction, study the pattern of injury and intensity, and timeline of occurrence of graft dysfunction. Retrospective study was carried out of 56 liver...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical and diagnostic research Vol. 9; no. 11; pp. EC17 - EC20
Main Authors Kanodia, K V, Vanikar, A V, Modi, P R, Patel, R D, Suthar, K S, Nigam, L K, Trivedi, H L
Format Journal Article
LanguageEnglish
Published India JCDR Research and Publications (P) Limited 01.11.2015
JCDR Research and Publications Private Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Liver biopsy is gold standard for diagnosis of allograft dysfunction. The aim of study was to evaluate liver allograft biopsies performed for graft dysfunction, study the pattern of injury and intensity, and timeline of occurrence of graft dysfunction. Retrospective study was carried out of 56 liver allograft biopsies and their histological findings with clinical presentation were correlated. Totally 56 needle liver allograft biopsies from January 1210 to July 2014, obtained from 35 patients were studied for histological and clinicopathological evaluation. The mean age was 53.2±5.48 years. The most common original disease was alcoholic cirrhosis. The most common histological lesion was acute cellular rejection (ACR) in 31 (55.36%) biopsies followed by preservation-reperfusion injury (PRI) in 10 (17.86%) biopsies and drug toxicity in 8 (14.29%) biopsies. Chronic rejection was reported in 2 (3.57%) and recurrence of HCV in 3 (5.36%). Ischemic coagulative necrosis and acute cholangitis were seen in 1 (1.79 %) case each. Alcoholic cirrhosis was the most common etiology for end stage liver disease. ACR and PRI were the major complications in liver allograft biopsies at our centre.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2249-782X
0973-709X
DOI:10.7860/JCDR/2015/13664.6812